Dana Investment Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Dana Investment Advisors's ELV Position: Q2 2026 in Review
Dana Investment Advisors reduced its Elevance Health (ELV) stake by 8.1% in Q2 2026, selling an estimated $475K and leaving 14,610 shares worth $5.65M. The position accounts for 0.15% of the portfolio, ranked #176.
Dana Investment Advisors first reported a position in ELV in Q2 2013 and has held it in 23 quarters since. The position peaked at $21.2M in Q1 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Dana Investment Advisors held 14,610 shares of Elevance Health worth $5.65M as of Q2 2026.
- Dana Investment Advisors sold 1,280 Elevance Health shares in Q2 2026, an estimated $475K.
- Elevance Health made up 0.15% of Dana Investment Advisors's portfolio in Q2 2026, its #176 holding.
- Dana Investment Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 23 quarters since.
- Dana Investment Advisors's Elevance Health position peaked at $21.2M in Q1 2023.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.